Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
podcast
Podcast
Health execs persevere in new policy landscape
Despite prolonged policy uncertainty in the U.S., executives at health companies are still seeing opportunities amid the tumult.
Fraiser Kansteiner
,
Ayla Ellison
May 15, 2026 9:10am
Revisiting Pharma’s tariff reality
May 8, 2026 9:07am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
A pivotal time for an RNA pioneer
May 1, 2026 8:30am
Can Trump’s UK deal become a drug pricing model?
Apr 24, 2026 9:00am
The top 10 pharma R&D budgets of 2025
Apr 10, 2026 9:28am